Reported Jan 18, 2023 · Terminated
Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland…
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174
Is this the product you have?
- Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only
- Manufactured forLupin Pharmaceuticals Baltimore, Maryland 21202
- Manufactured byLupin Limited Aurangabad 431 210 India. NDC 68180-659-06
- Lot codes and dates
Lot # A200171Exp 12/2023
- Amount recalled
- 16,056 30 count bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.